Comparison...
Prima Biomed
One candidate /higher risk of failure
Cvac in a Phase 2/b Trial, no results
Cvac in a Phase 2/3 Pivotal Trial, first enrolments just commenced.
$45 million cash at bank
Market opportunity for Cvac $3.6 billion +
Prima Biomed Market Cap $224 million
Neuren Pharmaceuticals
Multiple Candidates/reduced risk of failure
Multiple Trials/FDA approval for Phase2 NNZ2566 oral in progress.
$9 million cash at bank and TBI Trial funded by US army
Market opportunity for motiva/NNZ2566 $2-$4 Billion +
Neuren Pharmaceuticals Market cap $31 Million lol
Go Figure
exciting old link for new onlookers, page-2
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.00 |
Change
0.090(0.45%) |
Mkt cap ! $2.556B | |||
| Open | High | Low | Value | Volume |
| $19.88 | $20.07 | $19.73 | $11.80M | 591.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5901 | $19.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.00 | 3262 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |